Dr. Frank Bialystok

Throughout his life and career, Dr. Franklin Bialystok has been an educator, researcher and community activist.

Currently, Dr. Bialystok is a professor at the University of Toronto. His fields of academic research are the Holocaust, the Canadian Jewish Community, and Polish Jews in the 20th†Century.

From 1972 to 1987 he taught History for the Toronto Board of Education, while earning an M.A. from York University. From 1987 to 1988, Dr. Bialystok was a visiting scholar at Oxford University, and returned to formal studies at York in 1991, completing his Ph.D. in History in 1997.

Prior to his work at the University of Toronto, Dr. Bialystok taught at York University and the University of Waterloo. In 2001, he was the inaugural scholar-in-residence in Canadian Jewish Studies at Concordia University. Dr. Bialystok has lectured at academic conferences and universities in eight countries on four continents, and speaks in academic and community settings on a regular basis. His doctoral dissertation, Delayed Impact: The Holocaust and the Canadian Jewish Community, won the Tannenbaum Prize in Canadian Jewish History and was nominated for the Governor Generalís Award in non-fiction. Dr. Bialystok is also the Vice-President of the Association of Canadian Jewish Studies.

Dr. Bialystok has been active in community affairs for more than thirty years. Currently, he is Chair of Canadian Jewish Congress-Ontario Region, and sits on the national executive of the CJC. He is a member and past chair of the Education Committee of the Toronto Holocaust Centre. Dr. Bialystok is a founding member and past chair of the Polish-Jewish Heritage Foundation of Canada, for which he was awarded the Cavalier's Cross of the Order of Poland.

In addition to his work in the Jewish community, Dr. Bialystok has chaired a committee of 'Toronto Residents in Partnership' that awarded youth and businesses for their anti-racist work. He sits on the advisory committee of Canadian Friends of Peace Now and has also worked in various capacities with the Hepatitis†C Program Advisory Committee, the Canadian Liver Foundation and the Transplant Centre of the University Hospital Network